Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 18506764)

1.

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.

Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE; Children's Oncology Group.

Pediatr Blood Cancer. 2008 Sep;51(3):334-8. doi: 10.1002/pbc.21618.

2.

Risk of recurrence and survival after relapse in patients with Ewing sarcoma.

Stahl M, Ranft A, Paulussen M, Bölling T, Vieth V, Bielack S, Görtitz I, Braun-Munzinger G, Hardes J, Jürgens H, Dirksen U.

Pediatr Blood Cancer. 2011 Oct;57(4):549-53. doi: 10.1002/pbc.23040. Epub 2011 Mar 25.

PMID:
21442722
3.

Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol.

López Guerra JL, Márquez-Vega C, Ramírez-Villar GL, Cabrera P, Ordóñez R, Praena-Fernández JM, Ortiz MJ.

Clin Transl Oncol. 2012 Apr;14(4):294-301. doi: 10.1007/s12094-012-0798-y.

PMID:
22484637
4.

Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.

Orr WS, Denbo JW, Billups CA, Wu J, Navid F, Rao BN, Davidoff AM, Krasin MJ.

Ann Surg Oncol. 2012 Nov;19(12):3816-22. doi: 10.1245/s10434-012-2458-4. Epub 2012 Jun 28. Erratum in: Ann Surg Oncol. 2013 Dec;20 Suppl 3:S753. Shannon Orr, W [corrected to Orr, W Shannon].

PMID:
22739653
5.

Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.

Pappo AS, Anderson JR, Crist WM, Wharam MD, Breitfeld PP, Hawkins D, Raney RB, Womer RB, Parham DM, Qualman SJ, Grier HE.

J Clin Oncol. 1999 Nov;17(11):3487-93.

PMID:
10550146
6.

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999.

Rodriguez-Galindo C, Billups CA, Kun LE, Rao BN, Pratt CB, Merchant TE, Santana VM, Pappo AS.

Cancer. 2002 Jan 15;94(2):561-9.

PMID:
11900241
7.

Clinical outcomes of adult patients with relapsed Ewing sarcoma: a 30-year single-institution experience.

Robinson SI, Ahmed SK, Okuno SH, Arndt CA, Rose PS, Laack NN.

Am J Clin Oncol. 2014 Dec;37(6):585-91. doi: 10.1097/COC.0b013e318281d6ab.

PMID:
23466580
8.

Prognostic factors in primary nonmetastatic Ewing sarcoma of the rib in children and young adults.

Qureshi SS, Kembhavi S, Vora T, Ramadwar M, Laskar S, Talole S, Kurkure P.

J Pediatr Surg. 2013 Apr;48(4):764-70. doi: 10.1016/j.jpedsurg.2012.07.049.

PMID:
23583131
9.

Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.

Kinsella TJ, Glaubiger D, Diesseroth A, Makuch R, Waller B, Pizzo P, Glatstein E.

Int J Radiat Oncol Biol Phys. 1983 Dec;9(12):1955-60.

PMID:
9463099
10.

Ewing sarcoma of the hand or foot.

Froeb D, Ranft A, Boelling T, Paulussen M, Klco-Brosius S, Jürgens H, Dirksen U.

Klin Padiatr. 2012 Oct;224(6):348-52. doi: 10.1055/s-0032-1327607. Epub 2012 Nov 9.

PMID:
23143762
11.

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG.

Cancer. 2011 Jul 1;117(13):3027-32. doi: 10.1002/cncr.25840. Epub 2011 Jan 10.

12.

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER.

J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22.

13.

Outcomes and prognostic factors for Ewing-family tumors of the extremities.

Biswas B, Rastogi S, Khan SA, Mohanti BK, Sharma DN, Sharma MC, Mridha AR, Bakhshi S.

J Bone Joint Surg Am. 2014 May 21;96(10):841-9. doi: 10.2106/JBJS.M.00411.

PMID:
24875025
14.

Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.

Karski EE, Matthay KK, Neuhaus JM, Goldsby RE, Dubois SG.

Cancer Epidemiol. 2013 Feb;37(1):29-33. doi: 10.1016/j.canep.2012.08.006. Epub 2012 Sep 5.

15.

Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.

Hoffmann C, Ahrens S, Dunst J, Hillmann A, Winkelmann W, Craft A, Göbel U, Rübe C, Voute PA, Harms D, Jürgens H.

Cancer. 1999 Feb 15;85(4):869-77.

PMID:
10091764
16.
17.

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

Shankar AG, Ashley S, Craft AW, Pinkerton CR.

Med Pediatr Oncol. 2003 Mar;40(3):141-7.

PMID:
12518341
18.

Ewing's sarcoma: long-term follow-up in 49 patients treated from 1967 to 1989.

Mameghan H, Fisher RJ, O'Gorman-Hughes D, Bates EH, Huckstep RL, Mameghan J.

Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):431-8.

PMID:
8436521
19.

Ewing sarcoma: clinical state-of-the-art.

Potratz J, Dirksen U, Jürgens H, Craft A.

Pediatr Hematol Oncol. 2012 Feb;29(1):1-11. doi: 10.3109/08880018.2011.622034. Review.

PMID:
22295994
20.

Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.

Krasin MJ, Davidoff AM, Rodriguez-Galindo C, Billups CA, Fuller CE, Neel MD, Merchant TE.

Cancer. 2005 Jul 15;104(2):367-73.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk